Stock DXCM DEXCOM, INC.
Add to a list
To use this feature you must be a member
Log inSign up

DexCom, Inc.

Equities

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		After market 05:20:28 pm
138 USD +0.10% Intraday chart for DexCom, Inc. 127.8 -7.43%
11:00pm DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours MT
10:26pm Earnings Flash (DXCM) DEXCOM Posts Q1 EPS $0.32, vs. Street Est of $0.27 MT

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about DexCom, Inc.

DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours MT
Earnings Flash (DXCM) DEXCOM Posts Q1 EPS $0.32, vs. Street Est of $0.27 MT
Earnings Flash (DXCM) DEXCOM Posts Q1 Revenue $921M, vs. Street Est of $910.9M MT
John Chevedden Submits a Shareholder Proposal to DexCom CI
Myra K. Young Submits a Shareholder Proposal to DexCom CI
Dexcom Insider Sold Shares Worth $274,242, According to a Recent SEC Filing MT
BTIG Adjusts DexCom's Price Target to $156 From $150 MT
UBS Raises DexCom's Price Target to $163 From $153, Maintains Buy Rating MT
MD Revolution Partners with Dexcom to Integrate Continuous Glucose Monitoring Systems with Its Remote Care Management Platform CI
Citigroup Raises Price Target on DexCom to $161 From $148, Keeps Buy Rating MT
Dexcom Insider Sold Shares Worth $367,472, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $579,180, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $10,802,803, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $2,715,006, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $1,567,363, According to a Recent SEC Filing MT
Dexcom Insider Sold Shares Worth $1,182,680, According to a Recent SEC Filing MT
DexCom Initiated at Outperform by RBC, Price Target Set at $165 on View for Revenue Upside Amid Rapidly Expanding Market MT
DexCom is still in the running Our Logo
Sector Update: Health Care Stocks Higher Late Afternoon MT
Sector Update: Health Care Stocks Advance Wednesday Afternoon MT
DexCom Shares Rise After Prescription-Free Glucose Biosensor Wins FDA Clearance MT
US FDA clears use of first over-the-counter continuous glucose monitor RE
DexCom Says Prescription-Free Glucose Biosensor Wins FDA Clearance MT
US FDA clears use of first over-the-counter continuous glucose monitor RE
DexCom, Inc. Announces the FDA Clears Stelo by Dexcom ? the First Glucose Biosensor CI

Chart DexCom, Inc.

Chart DexCom, Inc.
More charts

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-04-24 - Q1 2024 Earnings Release
Related indices
S&P 500
More about the company

Income Statement Evolution

More financial data

Ratings for DexCom, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
137.9 USD
Average target price
149.3 USD
Spread / Average Target
+8.28%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
DEXCOM, INC. Stock DexCom, Inc.
+11.22% 54.6B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.92% 185B
MEDTRONIC PLC Stock Medtronic plc
-3.80% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.48% 67.55B
CENCORA, INC. Stock Cencora, Inc.
+16.74% 47.42B
HOYA CORPORATION Stock Hoya Corporation
+3.86% 42.24B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+4.56% 28.24B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+1.64% 26.42B
TERUMO CORPORATION Stock Terumo Corporation
+12.40% 25.66B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-1.60% 24.9B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. DXCM Stock
  4. News DexCom, Inc.
  5. DexCom : Oppenheimer Adjusts DexCom PT to $500 From $480, Maintains Outperform Rating